SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DRUG OMISSION REASON
The PATIENT clinical factors which resulted in Systemic Anti-Cancer Therapy drugs being omitted from the Systemic Anti-Cancer Therapy Drug Cycle.
Format / Length
an1
Description
SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DRUG OMISSION REASON is the same as attribute
SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DRUG OMISSION REASON. Record the clinical factors which resulted in modifying the cycle
National Codes
| Code | Description |
|---|---|
| 1 | Genomics, for example Dihydropyrimidine Dehydrogenase (DPD) enzyme variant |
| 2 | Frailty |
| 3 | Comorbidities |
| 8 | Other (not listed) |
Where Used
| Type | Link | How used |
|---|---|---|
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DRUG OMISSION REASON |